Company shared strong 2023 performance citing $38M in revenue and 43% YoY growth. Continued investments in R&D and commercial infrastructure set the table for continued revenue growth and pathway to profitability in 2024. PARSIPPANY, N.J., Feb. 13, 2024 /PRNewswire/ — Onkos Surgical, an…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.